Michael Joseph MacCourt Net Worth

The estimated Net Worth of Michael Joseph Maccourt is at least $722 Thousand dollars as of 3 June 2021. Mr Maccourt owns over 2,000 units of Electromed stock worth over $299,880 and over the last 4 years he sold ELMD stock worth over $0. In addition, he makes $421,750 as Chief Fin. Officer at Electromed.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

or

Sign up with Google Sign up with Facebook

Mr MacCourt ELMD stock SEC Form 4 insiders trading

Mr has made over 1 trades of the Electromed stock since 2021, according to the Form 4 filled with the SEC. Most recently he bought 2,000 units of ELMD stock worth $21,140 on 3 June 2021.

The largest trade he's ever made was buying 2,000 units of Electromed stock on 3 June 2021 worth over $21,140. On average, Mr trades about 500 units every 0 days since 2020. As of 3 June 2021 he still owns at least 17,000 units of Electromed stock.

You can see the complete history of Mr Maccourt stock trades at the bottom of the page.

Mr. Michael Joseph MacCourt biography

Michael Joseph MacCourt is the Chief Fin. Officer at Electromed.

What is the salary of Mr MacCourt?

As the Chief Fin. Officer of Electromed, the total compensation of Mr MacCourt at Electromed is $421,750. There are 2 executives at Electromed getting paid more, with Kathleen Skarvan having the highest compensation of $748,268.

How old is Mr MacCourt?

Mr MacCourt is 43, he's been the Chief Fin. Officer of Electromed since . There are 9 older and 1 younger executives at Electromed. The oldest executive at Electromed Inc. is George Winn, 83, who is the Independent Director.

What's Mr MacCourt's mailing address?

Michael's mailing address filed with the SEC is 500 SIXTH AVENUE NW, , NEW PRAGUE, MN, 56071.

Insiders trading at Electromed

Over the last 14 years, insiders at Electromed have traded over $2,585,226 worth of Electromed stock and bought 684,801 units worth $2,582,707 . The most active insiders traders include Oak Partners, Llc Red, Stephen H. Craney, and Kathleen Skarvan. On average, Electromed executives and independent directors trade stock every 84 days with the average trade being worth of $358,798. The most recent stock trade was executed by James L. Cunniff on 1 March 2024, trading 9,000 units of ELMD stock currently worth $137,250.

What does Electromed do?

electromed, inc. is a minnesota-based company (nyse mkt: elmd) and the innovative leader in the development, manufacture, and worldwide sales of the smartvest® airway clearance system. the patented system uses high frequency chest wall oscillation (hfcwo), a better-tolerated alternative to chest physiotherapy (cpt), to deliver vigorous, yet comfortable airway clearance treatment for patients battling the consequences of retained secretions. hfcwo has been clinically proven to clear the lungs of excess mucus, improve and reduce lung infections for individuals suffering from various conditions including atelectasis, copd, bronchiectasis, neuromuscular diseases, and cystic fibrosis. electromed, inc. is accredited by the joint commission and is iso 13485:2003 and iso 9001:2008 certified.

Complete history of Mr Maccourt stock trades at Electromed

Electromed executives and stock owners

Electromed executives and other stock owners filed with the SEC include:

• Kathleen Skarvan,
  President, Chief Executive Officer, Director
• Kathleen S. Skarvan,
  CEO, Pres & Director
• Michael Joseph MacCourt,
  Chief Fin. Officer
• Stephen Craney,
  Independent Chairman of the Board
• Michael MacCourt,
  Chief Financial Officer
• Stan Erickson,
  Independent Director
• Gregory Fluet,
  Independent Director
• Lee Jones,
  Independent Director
• George Winn,
  Independent Director
• Andrea Walsh,
  Independent Director
• Kalle Ahl,
  IR Contact Officer
• Kathryn Thompson,
  VP of Reimbursement
• William J. George,
  Sec.
• Bud Reeves,
  VP of Sales
• William Eckles,
  Director
• Jeremy T. Brock,
  Chief Financial Officer
• Oak Partners, Llc Red,
  10% owner
• John L Erb,
  Director
• Craig N. Hansen,
  Director
• James J. Cassidy,
  Chief Operating Officer
• Darrel L Kloeckner,
  Director
• Terry M. Belford,
  Chief Financial Officer
• Thomas M. Hagedorn,
  Director
• Robert D. Hansen,
  Chief Executive Officer
• Andrew Summers,
  Director
• Bradley M. Nagel,
  Chief Financial Officer
• Christopher G. Holland,
  Chief Commercial Officer
• Kathleen A Tune,
  Director
• Joseph L. Galatowitsch,
  Director
• Michelle C. Wirtz,
  Chief Financial Officer
• James L. Cunniff,
  CEO and President